Switching to aromatase inhibitor may lower risk of recurrence

by

A recent study, presented at the prestigious 31st Annual ┬áSan Antonio Breast Cancer Symposium, has found that women who switched to an aromatase inhibitor (AI) after two to three years of Tamoxifen lowered… Continue reading